Abstract
Background&Aims: Patients with advanced fibrosis related to nonalcoholic fatty liver disease(NAFLD) are at risk of developing hepatic and extrahepatic complications. Liver stiffness measurement(LSM)by FibroScan has a good diagnostic accuracy for advanced fibrosis and can also predict the occurrence of liver-related events in patients with chronic hepatitis C.Data about the accuracy of LSM in the prediction of events in NAFLD,especially in patients with NAFLD and F3-F4 fibrosis,are scarce. We investigated whether,in a large cohort of patients with NAFLD and compensated advanced chronic liver disease(cACLD),LSM at baseline,at follow-up,and its variations are accurate for the prediction of hepatic and extrahepatic events.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
